Amgen Inc (AMGN · NASDAQ)
AMGN · MARKET VIEW
Market view · as of Jul 20, 2026
Revenue (TTM)
$37.22B
+5.8% YoY
Gross margin
71.4%
EPS (latest q)
$5.15
vs $4.77 est · beat
52-wk position
84.2%
-4.9% vs 52w high · +7.2% 1mo
Price (last ~year)
Amgen Inc. (AMGN) holds a market capitalization of $197.69 billion and has surpassed earnings estimates for four consecutive quarters, most recently reporting $5.15 per share for the period ending March 31, 2026. The company generated $37.22 billion in TTM revenue with an operating margin of 33.8%, while maintaining $12.04 billion in cash against $57.32 billion in total debt. Recent institutional activity includes increased positions from the Swiss National Bank and SEB Asset Management, alongside a stake reduction by AlTi Global Inc.
Valuation
- Market cap
- $197.69B
- P/E
- 25.83
- PEG
- 2.008
- P/B
- 21.51
- P/S
- 5.31
- EV/EBITDA
- 14.57
- Beta
- 0.403
- Analyst target
- $356.62
Quality & returns
- Gross margin
- 71.4%
- Operating margin
- 33.8%
- Profit margin
- 21.0%
- ROE
- 101.3%
- ROA
- 8.3%
Price movement
- Last
- $366.29
- 1-month
- +7.2%
- 3-month
- +7.0%
- RSI (14)
- 56
- vs SMA200
- +9.0%
- 52-wk position
- 84.2% -4.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $8.62B | $2.67B | $1.82B | $3.86B |
| 2025-12-31 | $9.90B | $3.94B | $1.33B | $3.30B |
| 2025-09-30 | $9.56B | $2.53B | $3.22B | $5.91B |
| 2025-06-30 | $9.17B | $2.64B | $1.43B | $3.62B |
Recent news
- Neutral AlTi Global Inc. Cuts Stock Position in Amgen Inc. $AMGN · 2026-07-20
- Neutral FY2026 EPS Estimates for Amgen Lowered by Erste Group Bank · 2026-07-20
- Neutral Neurocrine Biosciences (NBIX) Stock Looks Reasonable At Today’s Price · 2026-07-19
- Neutral Swiss National Bank Buys 105,080 Shares of Amgen Inc. $AMGN · 2026-07-19
- Neutral Mediolanum International Funds Ltd Buys 7,075 Shares of Amgen Inc. $AMGN · 2026-07-19
- Neutral SEB Asset Management AB Purchases New Position in Amgen Inc. $AMGN · 2026-07-19
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)